Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|November 12, 2021
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cellsW Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, et al.Iscience|July 3, 2024
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.Biorxiv : the Preprint Server for Biology|May 27, 2024
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.Science Advances|May 13, 2022
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressorsXu Feng, Mengfan Tang, Merve Dede, et al.Gut|September 14, 2024
Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreasYuki Makino, Kimal I Rajapakshe, Benson Chellakkan Selvanesan, et al.Cancer Cell|August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potencyAlexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.Cancer Cell|August 13, 2024
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPDMayra Shanley, May Daher, Jinzhuang Dou, et al.Nature Medicine|January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trialDavid Marin, Ye Li, Rafet Basar, et al.Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.Nature|June 4, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cellsHind Rafei, Rafet Basar, Sunil Acharya, et al.Pageof 3